{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:25:18Z","timestamp":1793881518614,"version":"4.7.0"},"reference-count":57,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2026,10,3]]},"DOI":"10.1080\/14712598.2026.2724147","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:55:18Z","timestamp":1789991718000},"page":"1031-1043","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Threats to validity of the PESTO perispinal etanercept stroke trial: a document-based clinical trial evaluation"],"prefix":"10.1080","volume":"26","author":[{"given":"Edward","family":"Tobinick","sequence":"first","affiliation":[{"name":"Institute of Neurological Recovery (INR PLLC)","place":["Boca Raton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcven","family":"G\u00fcrb\u00fcz","sequence":"additional","affiliation":[{"name":"RN Clinics","place":["Aarhus, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1567275"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1346177"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57860-0"},{"key":"e_1_3_6_6_1","unstructured":"Stroke Foundation [Australia] Media Release. Return to life return to work research grants announced. [2019 Mar 18]."},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213981"},{"key":"e_1_3_6_8_1","unstructured":"Return to life return to work clinical research grants application Guide. Stroke foundation. 2018 FOI 26-2767 document 20."},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.03.020"},{"key":"e_1_3_6_10_1","unstructured":"FDA. International council for harmonisation (ICH) E3 (R1) structure and content of clinical study reports: questions and answers. 2013."},{"key":"e_1_3_6_11_1","unstructured":"FDA. ICH E6(R2) good clinical practice: integrated addendum to ICH E6(R1)."},{"key":"e_1_3_6_12_1","volume-title":"Statistical principles for clinical trials","author":"ICH E9","year":"1998","unstructured":"ICH E9. Statistical principles for clinical trials. London, UK: European Medicines Agency; 1998."},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000251"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004587"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081124"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081660"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1687"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1709822"},{"key":"e_1_3_6_19_1","unstructured":"Reply to request for PESTO data sharing. 2026. (Correspondence; reply from Thijs V. on behalf of PESTO Steering Committee to Tobinick E)."},{"key":"e_1_3_6_20_1","unstructured":"Letter to Florey for PESTO data sharing. 2026. (Correspondence; request from Tobinick E. to Thijs V.)."},{"key":"e_1_3_6_21_1","unstructured":"Austin health FOI request. 2026. (Personal correspondence; FOI request to Austin Health by Tobinick E)."},{"key":"e_1_3_6_22_1","unstructured":"Austin Health internal review decision produced 16 March 2026 in response to an FOI request dated 11 Feb 2026. Correspondence; Austin Health FOI response to Tobinick E."},{"key":"e_1_3_6_23_1","unstructured":"Site signature and delegation of responsibilities log produced under FOI 25\/26\u20131266 request to Austin Health 2026"},{"key":"e_1_3_6_24_1","unstructured":"Austin health HREC clarification request response produced on 30 March 2026 in response to a request for clarification of HREC complaint process. 2026. (Correspondence; between Austin Health Research Office and Tobinick E)."},{"key":"e_1_3_6_25_1","volume-title":"Essai sur les veines du rachis [Theses presentees et soutenues publiq. devant les juges concours le 28. Avril 1819]","author":"Breschet G.","year":"1819","unstructured":"Breschet G. Essai sur les veines du rachis [Theses presentees et soutenues publiq. devant les juges concours le 28. Avril 1819]. Paris: Faculte de Medecine de Paris; 1819."},{"key":"e_1_3_6_26_1","volume-title":"Recherches anatomiques physiologiques et pathologiques sur le syst\u00e1eme veineux","author":"Breschet G.","year":"1829","unstructured":"Breschet G. Recherches anatomiques physiologiques et pathologiques sur le syst\u00e1eme veineux. Paris: Rouen fr\u00e1eres; 1829."},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-194007000-00016"},{"issue":"2","key":"e_1_3_6_28_1","first-page":"195","article-title":"The vertebral vein system. Caldwell lecture, 1956","volume":"78","author":"Batson OV","year":"1957","unstructured":"Batson OV. The vertebral vein system. Caldwell lecture, 1956. Am J Roentgenol Radium Ther Nucl Med. 1957;78(2):195\u2013212.","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"1","key":"e_1_3_6_29_1","first-page":"53","article-title":"The cerebrospinal venous system: anatomy, physiology, and clinical implications","volume":"8","author":"Tobinick E","year":"2006","unstructured":"Tobinick E. The cerebrospinal venous system: anatomy, physiology, and clinical implications. MedGenmed. 2006;8(1):53.","journal-title":"MedGenmed"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e3182274865"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ca.22354"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.10.004"},{"key":"e_1_3_6_33_1","unstructured":"FDA. Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products guidance for industry FDA document FDA-2012-D-1145\u20130040 Silver Spring (MD): U.S. Food and Drug Administration Center for Biologics Evaluation and Research; 2019 Mar 15. Available from: https:\/\/www.regulations.gov\/document\/FDA-2012-D-1145-0040"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2024.2390636"},{"key":"e_1_3_6_35_1","unstructured":"Thijs V. Protocol v2.1 - a prospective multicentre phase 2b randomised controlled double-blind trial to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment PESTO protocol number 2 version: 2.1 date: 31 May 2022 author: Thijs V.N. Sponsor: Florey Institute of Neuroscience and Mental Health. Published as online supplemental material within the file esap_1 along with the corresponding Neurology\u00ae trial report volume 105 issue 6 4 Sept 2025. [clinical trial protocol]."},{"key":"e_1_3_6_36_1","doi-asserted-by":"crossref","unstructured":"Thijs V. PESTO protocol No.1 version 1.0 (30 May 2019) - a prospective multicentre phase 2b randomised controlled double-blind trial to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment author: Thijs V.N. Sponsor: Florey Institute of Neuroscience and Mental Health. Published as online supplemental material within the file esap_1 along with the corresponding Neurology\u00ae trial report Volume 105 Issue 6. 2025.","DOI":"10.1212\/WNL.0000000000213981"},{"key":"e_1_3_6_37_1","unstructured":"ANZCTR: Australian New Zealand clinical trials registry page for the PESTO perispinal etanercept stroke trial registered 7 October 2020 last updated 28 Sept 2025 [internet]. [cited 2026 Jan 31]. Available from: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=378447&isReview=true"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213981"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2012.00325"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2010.01.002"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17670-8"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000342200.58823.6a"},{"key":"e_1_3_6_43_1","unstructured":"Southern Health and Disability Ethics Committee. New Zealand 08 Sept 2020 minutes 20\/STH\/139 Perispinal Entanercept [Sic] in post stroke patients with moderate to severe disability. Available from: https:\/\/ethics.health.govt.nz\/about\/meeting-dates-venues-and-minutes\/southern-minutes\/"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/23969873241249248"},{"key":"e_1_3_6_45_1","unstructured":"Southern Health and Disability Ethics Committee. Annual report page 12 20\/STH\/139 approval on 11 December 2020. 2021. Available from: https:\/\/ethics.health.govt.nz\/about\/annual-reports\/"},{"key":"e_1_3_6_46_1","unstructured":"PESTO DSMB report - \u201cSAFETY REPORT for Data Safety Monitoring Board \u201d1 June 2022 produced under FOI 26\u20131740 request"},{"key":"e_1_3_6_47_1","unstructured":"Letter 12 May 2021 from the CEO of the stroke foundation to the department of industry science energy and resources produced under FOI 26\u20132767 request to the Australian government department of health disability and ageing document 25 entitled \u201cRE: MRFF-N-SF A17.04 accelerated research program: \u2018return to life return to work\u2019; available online by searching https:\/\/www.health.gov.au\/resources\/foi-disclosure-log\/foi-26-2767-clinical-trial-grant-funding"},{"key":"e_1_3_6_48_1","volume-title":"Thijs, V. Protocol v2.0 - a prospective multicentre, phase 2b randomised controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment. Sponsor","author":"Austin Health FOI 1561:25\/26, provided as a redacted file, Cover page only","unstructured":"Austin Health FOI 1561:25\/26, provided as a redacted file, Cover page only. Thijs, V. Protocol v2.0 - a prospective multicentre, phase 2b randomised controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment. Sponsor. Florey Institute of Neuroscience and Mental Health."},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050312116671725"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-200012150-00008"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000015030.59594.B3"},{"key":"e_1_3_6_52_1","volume-title":"Quality Metric Incorporated","author":"Ware JE","year":"2011","unstructured":"User\u2019s manual for the SF-36v2 health survey. In: Ware JE, Maruish M, editors. Quality Metric Incorporated: Lincoln, Rhode Island, USA. 2011."},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012552211996"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.000000000000010311"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-184"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209909"},{"key":"e_1_3_6_57_1","volume-title":"Declaration of Helsinki - ethical principles for medical research involving human participants","author":"World Medical Association","unstructured":"World Medical Association. Declaration of Helsinki - ethical principles for medical research involving human participants. JAMA;2025;333(1):71-74."},{"key":"e_1_3_6_58_1","unstructured":"Australian code for the responsible conduct of research. Available from: https:\/\/www.nhmrc.gov.au\/about-us\/publications\/australian-code-responsible-conduct-research-2018"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.24318\/cope.2019.1.4"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2724147","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14712598.2026.2724147","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2724147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:29:33Z","timestamp":1793878173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2026.2724147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,3]]}},"alternative-id":["10.1080\/14712598.2026.2724147"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2026.2724147","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}